Bristol Myers Squibb (BMY) Current Taxes (2009 - 2019)

Bristol Myers Squibb (BMY) has reported Current Taxes for 11 consecutive years, with $525.0 million the latest figure, recorded in Q1 2019.

• On a quarterly basis, Current Taxes rose 77.36% year-over-year to $525.0 million in Q1 2019; TTM through Mar 2019 was $525.0 million, a 77.36% increase from a year earlier, with the FY2018 full-year figure at $398.0 million, up 72.29% from the prior year.
• Current Taxes was $525.0 million for Q1 2019 at Bristol Myers Squibb, up from $398.0 million in the prior quarter.
• Over five years, Current Taxes peaked at $572.0 million in Q4 2015 and troughed at $98.0 million in Q2 2015.
• A 5-year average of $295.9 million and a median of $291.0 million in 2017 frame the typical range for Current Taxes.
• Across the five-year window, Current Taxes surged 118.32% in 2015 and tumbled 73.43% in 2016, its largest moves.
• Over 5 years, Current Taxes stood at $572.0 million in 2015, then plunged by 73.43% to $152.0 million in 2016, then surged by 51.97% to $231.0 million in 2017, then soared by 72.29% to $398.0 million in 2018, then jumped by 31.91% to $525.0 million in 2019.
• The last three Current Taxes figures came in at $525.0 million (Q1 2019), $398.0 million (Q4 2018), and $355.0 million (Q3 2018), per Business Quant data.